HIGH RISK NEUROBLASTOMA
Clinical trials for HIGH RISK NEUROBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new HIGH RISK NEUROBLASTOMA trials appear
Sign up with your email to follow new studies for HIGH RISK NEUROBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough cancer: Two-Year pill aims to keep neuroblastoma away
Disease control OngoingThis study is testing whether taking the drug eflornithine for two years can help keep cancer from coming back in children with high-risk neuroblastoma who have already finished their main treatments, including immunotherapy. Researchers will follow 20 children under 18 to see if…
Matched conditions: HIGH RISK NEUROBLASTOMA
Sponsor: Shanghai Children's Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for kids with Tough-to-Beat cancer
Disease control OngoingThis study is for children whose high-risk neuroblastoma has come back or hasn't responded to initial treatment. It tests whether adding a drug called eflornithine (DFMO) to a standard combination of chemotherapy and immunotherapy works better. The goal is to see if the new combi…
Matched conditions: HIGH RISK NEUROBLASTOMA
Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New hope for kids with tough cancer: trial tests supercharged treatment
Disease control OngoingThis study is testing whether adding an immunotherapy drug called dinutuximab to standard chemotherapy works better for children newly diagnosed with high-risk neuroblastoma, a serious childhood cancer. The trial involves 42 young patients and aims to see if this combination is s…
Matched conditions: HIGH RISK NEUROBLASTOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC